SEC Form 4 · accession 0001505148-16-000002
PSYCHEMEDICS CORP · PMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James V. Dyke
Officer — Vice President - Sales
Period of report
Nov 14, 2016
Accepted (ET)
Nov 16, 2016 · 2:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806517
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.005 Par ValueF1 | Nov 14, 2016 | S | 5,000 | $23.70 | D | 37,654 | D | |
| Common Stock, $.005 Par ValueF2 | Nov 15, 2016 | S | 5,000 | $23.42 | D | 32,654 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.30 to $23.83, inclusive. The reporting person undertakes to provide to Psychemedics Corp., any security holder of Psychemedics Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.08 to $23.75, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.